posted on 2021-09-13, 14:43authored byDavid Remillard, Nikolas A. Savage, Alexia T. Kedves, Joshiawa Paulk, Xin Chen, Francisco J. Garcia, Michael J. Romanowski, Patricia A. Horton, Jason Murphy, Markus Schirle, Edmund M. Harrington, Matthew B. Maxwell, Helen Trinh Pham, Igor Maksimovic, Jason R. Thomas, William C. Forrester
Bromodomain-containing
proteins frequently reside in multisubunit
chromatin complexes with tissue or cell state-specific compositions.
Recent studies have revealed tumor-specific dependencies on the BAF
complex bromodomain subunit BRD9 that are a result of recurrent mutations
afflicting the structure and composition of associated complex members.
To enable the study of ligand engaged complex assemblies, we established
a chemoproteomics approach using a functionalized derivative of the
BRD9 ligand BI-9564 as an affinity matrix. Unexpectedly, in addition
to known interactions with BRD9 and associated BAF complex proteins,
we identify a previously unreported interaction with members of the
NuA4 complex through the bromodomain-containing subunit BRD8. We apply
this finding, alongside a homology-model-guided design, to develop
chemical biology approaches for the study of BRD8 inhibition and to
arrive at first-in-class selective and cellularly active probes for
BRD8. These tools will empower further pharmacological studies of
BRD9 and BRD8 within respective BAF and NuA4 complexes.